Peptic Ulcer Disease
📧 Sign up to get email alerts when something new happens for Peptic Ulcer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-08-09Clinical Trial Update: The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients [Phase 4]
Phase 4 pilot study evaluating tailored eradication therapy for clarithromycin-resistant Helicobacter pylori in peptic ulcer disease.
-
FDA approval · 2018-07-23FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for Esomeprazole Magnesium. This approval authorizes the marketi…
-
FDA approval · 2018-07-20FDA Approved: OMEPRAZOLE — Original Application (INNOVUS PHARMACEUTICALS, INC.)
FDA approved a generic version of omeprazole (omeprazole and omeprazole magnesium) under ANDA210593 from Innovus Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis [NA]
A completed clinical trial evaluates early selective transcatheter arterial embolization to control severe bleeding from peptic ulcers after…
-
FDA approval · 2018-06-07FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) submitted by Wyeth Pharmaceuticals LLC (Pfize…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for Omeprazole by Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2018-06-07FDA Approved: OMEPRAZOLE — Supplemental Application (Golden State Medical Supply, Inc.)
The FDA approved a supplemental application for the generic omeprazole from Golden State Medical Supply, Inc., authorizing changes to the ap…
-
FDA approval · 2018-05-31FDA Approved: OMEPRAZOLE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for omeprazole from Aurobindo Pharma Limited, authorizing their generic omeprazole product.
-
FDA approval · 2018-04-30FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Sun Pharmaceutical Industries, Inc)
The FDA approved Sun Pharmaceutical's original application for Esomeprazole Magnesium, a proton pump inhibitor. It is used to treat gastroes…
-
FDA approval · 2018-04-24FDA Approved: RABEPRAZOLE SODIUM — Original Application (Ascend Laboratories, LLC)
FDA approved Rabeprazole sodium from Ascend Laboratories, LLC as an Original Application (ANDA 208644), authorizing a generic proton pump in…
-
FDA approval · 2018-04-13FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID Solutab (lansoprazole) from Takeda Pharmaceuticals America, Inc., indicating a regu…
-
FDA label_change · 2018-02-28FDA Approved: CYTOTEC — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Cytotec (misoprostol) from Pfizer, resulting in an update to the product labeling.
-
FDA approval · 2018-01-25FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for a combination product containing bismuth subcitrate potassium, metronidazole, and tetracycline h…
-
FDA approval · 2017-12-20FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX I.V., approving its intravenous pantoprazole sodium formulation. This expands treat…
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients [Phase 3]
Phase 3 trial in Chinese patients evaluated ilaprazole for treatment and prevention of peptic ulcer bleeding and has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents [NA]
Terminated clinical trial evaluating if second-look endoscopy reduces peptic ulcer rebleeding in patients who resume antiplatelet therapy ea…
-
FDA approval · 2017-08-18FDA Approved: KIRKLAND SIGNATURE ESOMEPRAZOLE MAGNESIUM — Original Application (Costco Wholesale Company)
The FDA approved the original generic application for Kirkland Signature Esomeprazole Magnesium, a generic version of esomeprazole magnesium…
-
CLINICAL_TRIALS research · 2017-08-17Clinical Trial Update: Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers
Completed observational study describing the natural history of bleeding peptic ulcers in the context of non-steroidal anti-inflammatory dru…
-
FDA approval · 2017-08-15FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for CARAFATE (sucralfate). This approval updates the product's labeling and/or indicati…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of Acetylsalicylic Acid (ASA) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fed Conditions [Phase 1]
This Phase 1 trial compared the bioavailability of two test products of a fixed-dose combination capsule containing aspirin 100 mg and panto…
-
FDA approval · 2017-07-06FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth/Pfizer to update the drug's labeling.
-
FDA approval · 2017-07-06FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application to authorize the intravenous formulation of Protonix (pantoprazole sodium) for specified indicat…
-
FDA approval · 2017-06-30FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Civica, Inc.)
The FDA approved Civica, Inc.'s pantoprazole sodium original application (NDA 209463), a proton pump inhibitor for acid-related conditions a…
-
FDA approval · 2017-06-26FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for pantoprazole sodium by XLCare Pharmaceuticals Inc., validating continued approval of their panto…
-
FDA approval · 2017-06-23FDA Approved: GLYCOPYRROLATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for a generic glycopyrrolate product from Somerset Therapeutics, LLC.